Sharing Life Sciences Innovations
Strong communication in biotech is lacking
Many biotech management teams fail to reach out to investors in a clear and appealing way.
Scientists unravel role of glutamine synthetase in the spread of cancer
Scientists have discovered an essential mechanism in the spread of cancer. A team led by professor Massimiliano Mazzone (VIB-KU Leuven) and professor Alessandra Castegna (University of Bari) has d…
Fighting plant diseases with the smell of freshly mown grass
Bioengineers at Ghent University have managed to protect wheat and rice from diseases by using substances made by plants themselves that spread the scent of freshly mown grass. Freshly mown gr…
UgenTec receives €50.000 grant by European Union
Under guidance of MINT, the Belgian PCR automation software company is one out of two Belgian companies to be granted and part of 36 grantees amongst 507 requests. UgenTec, the Belgian PCR aut…
IDO 1: a promising new target for immunotherapy
iTeos Therapeutics started in 2012 as a spin-off from the Ludwig Institute for Cancer Research (LICR), one of the top three cancer institutes in the world, and the UCL. In 2014, they licensed righ…
Immunotherapy: a paradigm shift in cancer treatment
An excerpt from the BioVox White paper on Cancer Immunotherapy.
Sylvie Janssens in Manhattan - Belgian scientist living abroad
Sylvie Janssens lives in Manhattan, New York, where she relocated after earning her PhD in biotechnology at Ghent University. She studied biomedical sciences at Ghent University, and prior to that…
Lars Klareskog pushes rheumatology beyond symptomatic treatment
Over the years, the perception of inflammatory diseases has changed drastically. The advent of cytokine inhibitors meant great improvement to many patients, especially those suffering from rheumat…
Reinforcing veins with computer simulations
Each year, more than two million patients worldwide undergo a procedure called coronary artery bypass grafting (CABG). CABG is used to treat blocked arteries and restore normal blood flow to the h…
Diagnosing rare genetic conditions within minutes
Moon is a new software package that, within minutes, diagnoses patients who suffer from rare diseases. All the software requires are the patient’s symptoms and sequencing data. Moon then applies a…
Curing all diseases in the next 20 years: the new hype amongst billionaires?
Despite the initial intent of charitable foundations to be not-for-profit, some of them tend to morph into organizations with bigger aspirations.
Investing in European biotech faced with many challenges
Investing in biotech companies is a capital-intensive and risky business, and it’s no secret that more money and less risk-averse investors are available in the US than in Europe. To keep innovati…
Join our 20.000 subscribers and receive the newsletter for free!
Upcoming events
Immunity for Health 2017
Elzenveld, Lange Gasthuisstraat 45, 2000 Antwerpen
Sun 20 Aug 2017
08:30
On October 20th 2017 Flanders Vaccine is happy to host its second edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and anima…
Medicin Paris Region Networking Event
Château des thermes de Chaudfontaine, Rue Hauster 9 à Chaudfontaine
Sat 26 Aug 2017
13:30
On August 26, 2017, AWEX is organizing a networking event between members of the competitiveness cluster Medicen Paris Region and BioWin, focusing on two strategic themes for these two regions, in…
Liquid biopsies & cancer
University Hall, Naamsestraat 22, Leuven
Mon 28 Aug 2017 - Wed 30 Aug 2017
28 Aug 08:30
- 30 Aug 17:00
The Leuven Cancer Institute (LKI) is happy to announce its upcoming symposium on "Liquid Biopsies & Cancer", on August 28-30, 2017 in Leuven (University Hall). The symposium is organised by th…
